Improving pain management after hand assisted laparoscopic surgery for kidney cancer
Phase 1
- Conditions
- The postoperative pain after Hand assisted lap.nephrectomy operation.Our one year retrospective study of patients with Kidney cancer treated with Hand assisted lap.nephrectomy revealed that, 71% of all patients undergoing Hand assisted lap.nephrectomy operation had a NRS score 3-10, and they needed substantial amounts of opioids to alleviate the postoperative painTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2017-002130-23-DK
- Lead Sponsor
- Zealand university hospital Roskilde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Performing elective hand.ass.lap. nephrectomu in general anesthesia, Received written and oralinformation about the study and sign the informed consent form of participating the study, ASA 1-3
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 30
Exclusion Criteria
Unabel to understand Danish in written or spoken language, Unable to Cooperato to the procedure, daily use of opioidsKnown abouse of alcohol ore medicationDiffcuilities in visualizing nerve ore muscle structure necessary for performing the block
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To demonstrate whether a unilateral USG TQL block can reduce opioid consumption with clinical significance in kidney cancer patients operated with hand ass. lap nephrectomy;Secondary Objective: not applicable;Primary end point(s): total doses of Opioid during the first 12 postoperative hours;Timepoint(s) of evaluation of this end point: 12 hours
- Secondary Outcome Measures
Name Time Method Secondary end point(s): Total dose of opioids during the first 24 hours,NRS (0-10) pain scores at rest, time in recovery, time to ambulation, total Length of stay. Adverse effects of oipiods;Timepoint(s) of evaluation of this end point: 24 hours